KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingTax ProvisionsTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Omega Healthcare Investors (OHI) over the last 17 years, with Q4 2025 value amounting to $51.7 million.

  • Omega Healthcare Investors' Interest Expenses fell 633.06% to $51.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $215.0 million, marking a year-over-year decrease of 301.33%. This contributed to the annual value of $215.0 million for FY2025, which is 301.33% down from last year.
  • As of Q4 2025, Omega Healthcare Investors' Interest Expenses stood at $51.7 million, which was down 633.06% from $58.1 million recorded in Q3 2025.
  • Omega Healthcare Investors' Interest Expenses' 5-year high stood at $59.4 million during Q4 2023, with a 5-year trough of $51.7 million in Q4 2025.
  • Moreover, its 5-year median value for Interest Expenses was $58.2 million (2021), whereas its average is $57.0 million.
  • In the last 5 years, Omega Healthcare Investors' Interest Expenses soared by 869.3% in 2021 and then crashed by 958.15% in 2025.
  • Quarter analysis of 5 years shows Omega Healthcare Investors' Interest Expenses stood at $58.2 million in 2021, then grew by 0.45% to $58.5 million in 2022, then increased by 1.61% to $59.4 million in 2023, then decreased by 7.05% to $55.2 million in 2024, then decreased by 6.33% to $51.7 million in 2025.
  • Its Interest Expenses stands at $51.7 million for Q4 2025, versus $58.1 million for Q3 2025 and $52.9 million for Q2 2025.